Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
BSS (Balanced Salt Solution) is a sterile irrigation solution used during ophthalmic surgery to maintain the anterior chamber and protect corneal endothelium. It contains essential electrolytes, glucose, and glutathione formulated to maintain corneal clarity and stability during surgical procedures. The product is indicated for intraocular irrigation during cataract surgery and other anterior segment procedures.
Limited growth potential as an established, mature ophthalmic adjunct with modest Medicare utilization; team size likely small and stable.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
The Evaluation of Balanced Salt Solution During Cataract Surgery
Spinal Cord Stimulation Versus Instrumentation for FBSS
First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts
Hospital Avoidance Strategies for ABSSSI
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Worked on BSS at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on BSS offers limited high-visibility career advancement opportunities due to the product's mature lifecycle stage and approaching loss of exclusivity. Roles are predominantly operational and cost-focused, suitable for professionals seeking stability in a niche ophthalmic segment rather than dynamic growth trajectories.